Page last updated: 2024-11-08

negletein

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

negletein: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID471719
CHEMBL ID296800
CHEBI ID190121
SCHEMBL ID718970
MeSH IDM0494606

Synonyms (30)

Synonym
4h-1-benzopyran-4-one, 5,6-dihydroxy-7-methoxy-2-phenyl-
5,6-dihydroxy-7-methoxy-2-phenyl-chromen-4-one
5,6-dihydroxy-7-methoxy-2-phenyl-4h-chromen-4-one
baicalein-7-methylether
29550-13-8
negletein
CHEMBL296800 ,
LMPK12111097
5,6-dihydroxy-7-methoxy-2-phenylchromen-4-one
CHEBI:190121
ST055981
A819959
5,6-dihydroxy-7-methoxy-2-phenyl-1-benzopyran-4-one
7-methoxy-5,6-bis(oxidanyl)-2-phenyl-chromen-4-one
FT-0619824
SCHEMBL718970
AKOS024282370
5,6-dihydroxy-7-methoxyflavone
ZTHLHHDJRXJGRX-UHFFFAOYSA-N
7-o-methylbaicalein
DTXSID50183736
mfcd00017458
ncgc00385058-01!5,6-dihydroxy-7-methoxy-2-phenylchromen-4-one
HY-N4285
bdbm50212750
BCP33551
5,6-dihydroxy-7-methoxyflavone;7-o-methylbaicalein
CS-0032637
MS-24037
E80605

Research Excerpts

Effects

ExcerptReferenceRelevance
"Negletein has been shown to have therapeutic potential for inflammation-associated diseases, but its effect on neurite outgrowth is still unknown. "( Negletein as a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells.
Bovicelli, P; Phan, CW; Righi, G; Sabaratnam, V; Saso, L, 2016
)
3.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID79285Effective concentration against HIV-1 replication in H9 lymphocytic cells; No suppression2003Bioorganic & medicinal chemistry letters, May-19, Volume: 13, Issue:10
Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos.
AID79287Concentration that inhibits uninfected H9 cell growth by 50%.2003Bioorganic & medicinal chemistry letters, May-19, Volume: 13, Issue:10
Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos.
AID1668637Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control2020Journal of natural products, 05-22, Volume: 83, Issue:5
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's9 (69.23)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]